Skip to content
BidBenchmark

Contract award

THE INSTITUTE FOR CANCER RESEARCH

PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE BIOMARKERS TASK ORDER TITLE: SULFORAPHANE FOR THE PREVENTION OF MALIGNANT MESOTHELIOMA
PIID
75N91023F00003
Award key
CONT_AWD_75N91023F00003_7529_75N91019D00022_7529
Recipient UEI
FF1XVJMDYVR1
Parent award
7529
Source as of
Aug 6, 2026
Current award value
$1,199,2743
Obligated to date
$1,199,2742
Potential with options
$1,199,2743
Awarding agency
Department of Health and Human ServicesNational Institutes of Health
Place of performance
Philadelphia, Pennsylvania
Set-aside
None
Pricing
FIRM FIXED PRICE
Competition
1 offers received
Period of performance
May 3, 2023May 2, 2027Through May 2, 2027 if all options are exercised
Benchmark category
Unclassified

Transaction history

Every action recorded against this award, in the order the government reported them.

ModAction dateReasonObligationValue at action
P00001Apr 7, 2026SUPPLEMENTAL AGREEME$0.00$1,199,274.00

Provenance

Which source record produced each displayed rollup figure.

FieldSourceFileRetrievedParserArtifact hash
awarding_agency_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
contractor_idUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
current_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
naics_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
potential_award_valueUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
psc_codeUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585
total_obligatedUSAspending.govFY2026_All_Contracts_Full_20260807_2.csvAug 10, 2026usaspending_contract_csv@2026.08.124edb1916585

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

This page is a record of one federal award, assembled from the transactions the government published against it. Note 1 describes where the rollup came from. Values are award values, not unit prices.

  1. 1Rollup values derive from 1 transaction records parsed from USAspending.gov (FY2026_All_Contracts_Full_20260807_2.csv), retrieved Aug 10, 2026 by transform awards@2026.08.1.
  2. 2Obligations are the sum of signed federal action obligations across all transactions; deobligations are negative and remain negative.
  3. 3Current and potential award values are taken from the latest reported action, not summed across modifications.
75N91023F00003 — THE INSTITUTE FOR CANCER RESEARCH · BidBenchmark